Researchers Discover Cancers of Epigenetic Origin without DNA Mutation
French National Centre for Scientific Research
Scientists demonstrate that genetic mutations are not essential for the development of cancer
epigenetics
New Clues on What Causes Gestational Diabetes
Harvard Pilgrim Health Care Institute
New study suggests the placenta is a key factor in the development of gestational diabetes
Elevating Cancer Diagnostics and Treatment Using Epigenetics
Moshe Szyf, PhD
Integrating epigenetic insights into cancer research could help deliver personalized, high-quality, and cost-effective patient care
New Study Unveils a Potential Pan-Cancer Biomarker
Impact Journals, LLC
Bioinformatics and epigenetic analyses link XRCC1 to some 10 cancer types
New Blood Test Detects Advanced Prostate Cancer Subtypes
Swathi Kodaikal, MSc
Liquid biopsy method uses methylated cell-free DNA to identify, classify, and quantify tumor burden and type
Transposable Elements Causing Rare MSL3 Syndrome Identified
Queen Mary University of London
Mutations in the MSL3 gene can lead to a global delay in the development of multiple organs in children
Can Chromosomal Instability Drive Epigenetic Alterations in Cancer Cells?
Memorial Sloan Kettering Cancer Center
Sequestration of chromosomes into micronuclei disrupts the organization of chromatin and triggers epigenetic dysregulation
New, Robust Approach for Understanding Population Epigenetic Variation
Swathi Kodaikal, MSc
CoRSIVs help precisely link genetic traits to disease risk in populations
Targeting Disease-Linked Mutations by Using Focused Actionable Exome Sequencing
Today's Clinical Lab, QIAGEN
Join Today's Clinical Lab and Peter Hahn, PhD, to learn about advantages of and approaches to exome sequencing for rare disease identification
Epigenetics Breaks into the Clinical Practice of Cancer
Josep Carreras Leukaemia Research Institute
Researchers describe the impact of epigenetics on cancer treatment and early detection